NVST लाइव सिग्नल्स | Getagraph.com के साथ लाभ को अधिकतम करें

Live Chart Being Loaded With Signals

Commentary (4 May 2024 @ 01:30):

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally...

Stats
आज की मात्रा	2.12M
औसत मात्रा	2.44M
बाजार मूल्य	3.27B
EPS	$0 ( 2024-05-01 )
अगली कमाई की तारीख	( $0.310 ) 2024-07-31
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-26.03
ATR14	$0.0170 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Keel Paul A	Buy	0
2024-04-15	Hulit Barbara B.	Buy	13 065	Common Stock
2024-03-15	Hulit Barbara B.	Buy	11 705	Common Stock
2024-02-25	Kaabi Faez C	Buy	30 915	Common Stock
2024-02-25	Kaabi Faez C	Buy	20 620	Employee Stock Option (Right to Buy)

INSIDER POWER
62.62
Last 99 transactions
Buy: 824 434 \| Sell: 239 403

मात्रा सहसंबंध

लंबा: -0.29 (neutral)

छोटा: -0.99 (very strong negative)

Signal:(38.399) Neutral

Envista Holdings Corp सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध

10 सबसे अधिक नकारात्मक सहसंबंध

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Envista Holdings Corp सहसंबंध - मुद्रा/वस्त्र

-0.18
( neutral )

-0.14
( neutral )

0.00
( neutral )

0.23
( neutral )

-0.67
( moderate negative )

0.24
( neutral )

Envista Holdings Corp वित्तीय

Annual	2023
राजस्व:	$2.57B
सकल लाभ:	$1.44B (56.13 %)
EPS:	$-0.600

FY	2023
राजस्व:	$2.57B
सकल लाभ:	$1.44B (56.13 %)
EPS:	$-0.600

FY	2022
राजस्व:	$2.57B
सकल लाभ:	$1.47B (57.41 %)
EPS:	$1.460

FY	2021
राजस्व:	$2.51B
सकल लाभ:	$1.43B (56.86 %)
EPS:	$2.11

Financial Reports:

No articles found.

Envista Holdings Corp

Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists, and periodontists under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, and Orascoptic brands; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Insignia, AOA, and Spark brands. This segment also offers software packages, which include DTX Studio Implant for treatment planning of dental implants; TX Studio Lab for prosthetics treatment planning; and DTX Studio Clinic to store and access a various clinical patient images. The company's Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, sensors, software, and other visualization/magnification systems; endodontic systems and related consumables; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.